IGFBP3 and systemic sclerosis: Of note, total IGF-1 and IGFBP-3 were significantly reduced SSc patients compared to HS (13–8.9 ng/ml, p < 0.05; and 806–694 ng/ml, p < 0.05, respectively) (Fig. 2a,d).